2024 Neuro-Oncology Update: Brain Tumors

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Find latest Central Nervous System videos · 100+ videos

Playback speed

10 seconds

2024 Neuro-Oncology Update: Brain Tumors

By Scripps Health FEATURING Tresa McGranahan

1,112 views

April 2, 2024

Disclaimer: On August 6, 2024, the FDA approved vorasidenib (Voranigo) for adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation, following surgery including biopsy, sub-total resection, or gross total resection.

Comments 1